Examining financial factors in prostate cancer treatment patterns

“I think the key [is to not] get rid of financial incentives. I don't think that's possible. [Rather, we should] align financial incentives [so] that [we] can promote what is best for patients,” says Lillian Y. Lai, MD.

In this video, Lillian Y. Lai, MD, discusses the findings of the Urology Practice study, “Commercial prices for prostatectomy and treatment among younger, privately insured men with prostate cancer.” Lai is a Society of Urologic Oncology fellow at the University of Michigan, Ann Arbor.